{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:15:18Z","timestamp":1793146518596,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.tube.2023.102412","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:54:38Z","timestamp":1695606878000},"page":"102412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["In vitro antimycobacterial activity and interaction profiles of diarylthiourea-copper (II) complexes with antitubercular drugs against Mycobacterium tuberculosis isolates"],"prefix":"10.1016","volume":"143","author":[{"given":"Anna","family":"Bielenica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"G\u0142ogowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Augustynowicz- Kope\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Orzelska-G\u00f3rka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmara","family":"Kurpios-Piec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Struga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tube.2023.102412_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/20734735.0149-2021","article-title":"New developments in tuberculosis diagnosis and treatment","volume":"18","author":"Gill","year":"2022","journal-title":"Breathe"},{"key":"10.1016\/j.tube.2023.102412_bib2","series-title":"Global tuberculosis report 2022","year":"2022"},{"issue":"7","key":"10.1016\/j.tube.2023.102412_bib3","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American thoracic society\/centers for disease control and prevention\/infectious diseases society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.tube.2023.102412_bib4","series-title":"WHO operational handbook on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","year":"2022"},{"issue":"5","key":"10.1016\/j.tube.2023.102412_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3346\/jkms.2016.31.5.649","article-title":"Diagnosis and treatment of nontuberculous mycobacterial lung disease","volume":"31","author":"Kwon","year":"2016","journal-title":"J Kor Med Sci"},{"issue":"11","key":"10.1016\/j.tube.2023.102412_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41579-022-00731-y","article-title":"Anti-tuberculosis treatment strategies and drug development: challenges and priorities","volume":"20","author":"Dartois","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.tube.2023.102412_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1215294","article-title":"Editorial: drug-resistant Mycobacterium tuberculosis","volume":"13","author":"Boshoff","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.tube.2023.102412_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bioorg.2018.06.027","article-title":"Enhancement in anti-tubercular activity of indole based thiosemicarbazones on complexation with copper(I) and silver(I) halides: structure elucidation, evaluation and molecular modelling","volume":"80","author":"Khan","year":"2018","journal-title":"Bioorg Chem"},{"issue":"47","key":"10.1016\/j.tube.2023.102412_bib9","doi-asserted-by":"crossref","first-page":"17350","DOI":"10.1039\/D0DT03104F","article-title":"Copper(I) and silver(I) complexes of anthraldehyde thiosemicarbazone: synthesis, structure elucidation, in vitro anti-tuberculosis\/cytotoxic activity and interactions with DNA\/HSA","volume":"49","author":"Khan","year":"2020","journal-title":"Dalton Trans"},{"key":"10.1016\/j.tube.2023.102412_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jinorgbio.2018.03.010","article-title":"Three new platinum complexes containing fluoroquinolones and DMSO: cytotoxicity and evaluation against drug-resistant tuberculosis","volume":"183","author":"de Oliveira","year":"2018","journal-title":"J Inorg Biochem"},{"issue":"11","key":"10.1016\/j.tube.2023.102412_bib11","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1016\/j.ejmech.2009.06.032","article-title":"Antitumor and antimycobacterial activities of cyclopalladated complexes: X-ray structure of [Pd(C2,N-dmba)(Br)(tu)] (dmba=N,N-dimethylbenzylamine, tu=thiourea)","volume":"44","author":"Moro","year":"2009","journal-title":"Eur J Med Chem"},{"issue":"8","key":"10.1016\/j.tube.2023.102412_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e10125","article-title":"ON donor tethered copper (II) and vanadium (V) complexes as efficacious anti-TB and anti-fungal agents with spectroscopic approached HSA interactions","volume":"8","author":"Sinha","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.tube.2023.102412_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jinorgbio.2017.04.024","article-title":"Novel copper(II) complexes with hydrazides and heterocyclic bases: synthesis, structure and biological studies","volume":"172","author":"Paixao","year":"2017","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.tube.2023.102412_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2021.111543","article-title":"Copper(II) complexes based on thiosemicarbazone ligand: preparation, crystal structure, Hirshfeld surface, energy framework, antiMycobacterium activity, in silico and molecular docking studies","volume":"223","author":"Souza","year":"2021","journal-title":"J Inorg Biochem"},{"key":"10.1016\/j.tube.2023.102412_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jphotobiol.2016.08.010","article-title":"Design, synthesis, structural elucidation, pharmacological evaluation of metal complexes with pyrazoline derivatives","volume":"163","author":"Muneera","year":"2016","journal-title":"J Photochem Photobiol, B"},{"issue":"11","key":"10.1016\/j.tube.2023.102412_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21113965","article-title":"Copper coordination compounds as biologically active agents","volume":"21","author":"Krasnovskaya","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.tube.2023.102412_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000443496","article-title":"Potential of casiopeinas(R) copper complexes and antituberculosis drug combination against Mycobacterium tuberculosis","volume":"61","author":"Barbosa","year":"2016","journal-title":"Chemotherapy"},{"issue":"22","key":"10.1016\/j.tube.2023.102412_bib18","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1007\/s00018-007-7310-9","article-title":"Type-2 copper-containing enzymes","volume":"64","author":"MacPherson","year":"2007","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"10.1016\/j.tube.2023.102412_bib19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10534-016-9968-7","article-title":"Synthesis and evaluation of copper(II) complexes with isoniazid-derived hydrazones as anticancer and antitubercular agents","volume":"29","author":"Firmino","year":"2016","journal-title":"Biometals"},{"issue":"10","key":"10.1016\/j.tube.2023.102412_bib20","doi-asserted-by":"crossref","first-page":"5765","DOI":"10.1128\/AAC.00325-16","article-title":"8-Hydroxyquinolines are boosting agents of copper-related toxicity in Mycobacterium tuberculosis","volume":"60","author":"Shah","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.tube.2023.102412_bib21","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/iub.2002","article-title":"The evaluation of the anti-cancer drug elesclomol that forms a redox-active copper chelate as a potential anti-tubercular drug","volume":"71","author":"Ngwane","year":"2019","journal-title":"IUBMB Life"},{"issue":"21","key":"10.1016\/j.tube.2023.102412_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111415","article-title":"The cytotoxic effect of copper (II) complexes with halogenated 1,3-disubstituted arylthioureas on cancer and bacterial cells","volume":"22","author":"Chrzanowska","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"44","key":"10.1016\/j.tube.2023.102412_bib23","doi-asserted-by":"crossref","first-page":"15539","DOI":"10.1039\/c2cp42185b","article-title":"Molecular recognition between DNA and a copper-based anticancer complex","volume":"14","author":"Galindo-Murillo","year":"2012","journal-title":"Phys Chem Chem Phys"},{"issue":"13","key":"10.1016\/j.tube.2023.102412_bib24","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1080\/00958972.2019.1656334","article-title":"Synthesis, structure, computational modeling and biological activity of two new Casiopeinas (R) complexes and their nanoparticles","volume":"72","author":"Malekshah","year":"2019","journal-title":"J Coord Chem"},{"key":"10.1016\/j.tube.2023.102412_bib25","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tube.2017.08.011","article-title":"Pharmacokinetic studies of a three-component complex that repurposes the front line antibiotic isoniazid against Mycobacterium tuberculosis","volume":"107","author":"Manning","year":"2017","journal-title":"Tuberculosis"},{"issue":"44","key":"10.1016\/j.tube.2023.102412_bib26","doi-asserted-by":"crossref","first-page":"10923","DOI":"10.1039\/C5OB01452B","article-title":"Thiourea-based spacers in potent divalent inhibitors of Pseudomonas aeruginosa virulence lectin LecA","volume":"13","author":"Pukin","year":"2015","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.tube.2023.102412_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ejmech.2016.08.060","article-title":"Biological evaluation of some new N-(2,6-dimethoxypyrimidinyl) thioureido benzenesulfonamide derivatives as potential antimicrobial and anticancer agents","volume":"124","author":"Ghorab","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2023.102412_bib28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejmech.2015.10.047","article-title":"Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties","volume":"107","author":"Joshi","year":"2016","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2023.102412_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejmech.2015.06.027","article-title":"Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl)phenyl moiety","volume":"101","author":"Bielenica","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2023.102412_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jinorgbio.2018.01.005","article-title":"Synthesis, structural and antimicrobial studies of type II topoisomerase-targeted copper(II) complexes of 1,3-disubstituted thiourea ligands","volume":"182","author":"Bielenica","year":"2018","journal-title":"J Inorg Biochem"},{"issue":"8","key":"10.1016\/j.tube.2023.102412_bib31","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1021\/acs.chemrestox.1c00164","article-title":"Further insights into the oxidative pathway of thiocarbonyl-type antitubercular prodrugs: ethionamide, thioacetazone, and isoxyl","volume":"34","author":"de Freitas Paulo","year":"2021","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.tube.2023.102412_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112402","article-title":"Design and synthesis of thiourea-based derivatives as Mycobacterium tuberculosis growth and enoyl acyl carrier protein reductase (InhA) inhibitors","volume":"199","author":"Dogan","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.tube.2023.102412_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1021\/id500032q","article-title":"Covalent modification of the Mycobacterium tuberculosis FAS-II dehydratase by isoxyl and thiacetazone","volume":"1","author":"Grzegorzewicz","year":"2015","journal-title":"ACS Infect Dis"},{"issue":"6","key":"10.1016\/j.tube.2023.102412_bib34","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1002\/ddr.21958","article-title":"Urea derivatives carrying a thiophenylthiazole moiety: design, synthesis, and evaluation of antitubercular and InhA inhibitory activities","volume":"83","author":"Keles Atici","year":"2022","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.tube.2023.102412_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100257","article-title":"Rediscovery of PF-3845 as a new chemical scaffold inhibiting phenylalanyl-tRNA synthetase in Mycobacterium tuberculosis","volume":"296","author":"Wang","year":"2021","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.tube.2023.102412_bib36","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.chembiol.2021.09.002","article-title":"Identification of cell wall synthesis inhibitors active against Mycobacterium tuberculosis by competitive activity-based protein profiling","volume":"29","author":"Li","year":"2022","journal-title":"Cell Chem Biol"},{"issue":"6","key":"10.1016\/j.tube.2023.102412_bib37","article-title":"Efficient synthesis of benzothiazinone analogues with activity against intracellular Mycobacterium tuberculosis","volume":"17","author":"Richter","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.tube.2023.102412_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116506","article-title":"Antimycobacterial and anti-inflammatory activities of thiourea derivatives focusing on treatment approaches for severe pulmonary tuberculosis","volume":"53","author":"Calixto","year":"2022","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.tube.2023.102412_bib39","first-page":"1","article-title":"Isoxazole carboxylic acid methyl ester-based urea and thiourea derivatives as promising antitubercular agents","author":"Sahoo","year":"2022","journal-title":"Mol Divers"},{"issue":"3","key":"10.1016\/j.tube.2023.102412_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01161-22","article-title":"Chemical exploration of a highly selective scaffold with activity against intracellular Mycobacterium tuberculosis","volume":"10","author":"Njikan","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.tube.2023.102412_bib41","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/JCM.36.2.362-366.1998","article-title":"Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay","volume":"36","author":"Franzblau","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2023.102412_bib42","series-title":"CLSI standard M24","article-title":"CLSI susceptibility testing of mycobacteria, nocardia spp. and other aerobic actinomycetes","author":"Wayne","year":"2018"},{"key":"10.1016\/j.tube.2023.102412_bib43","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ejps.2018.05.024","article-title":"Do new N-substituted 3-amino-4-phenyl-5-oxo-pyrazolinecarboxamide derivatives exhibit antitubercular potential?","volume":"121","author":"Swatko-Ossor","year":"2018","journal-title":"Eur J Pharmaceut Sci"},{"key":"10.1016\/j.tube.2023.102412_bib44","series-title":"Microbiology; ASM. Clinical microbiology procedures handbook","article-title":"Synergism testing: broth microdilution checkerboard and broth macrodilution methods","author":"Hd","year":"1992"},{"issue":"8","key":"10.1016\/j.tube.2023.102412_bib45","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1128\/AAC.36.8.1695","article-title":"Bacteriostatic and bactericidal activities of gentamicin alone and in combination with clarithromycin against Mycobacterium avium","volume":"36","author":"Heifets","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.tube.2023.102412_bib46","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijantimicag.2018.09.019","article-title":"In vitro evaluation of dinactin, a potent microbial metabolite against Mycobacterium tuberculosis","volume":"53","author":"Hussain","year":"2019","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.tube.2023.102412_bib47","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/ajcp\/101.3.329","article-title":"Application of new technology to the detection, identification, and antimicrobial susceptibility testing of mycobacteria","volume":"101","author":"Pfaller","year":"1994","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"10.1016\/j.tube.2023.102412_bib48","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5114\/aoms.2012.29216","article-title":"Comparison of the GenoType((R)) MTBC molecular genetic assay with culture methods in the diagnosis of tuberculosis","volume":"10","author":"Kurtoglu","year":"2014","journal-title":"Arch Med Sci"},{"issue":"1","key":"10.1016\/j.tube.2023.102412_bib49","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/JCM.44.1.20-28.2006","article-title":"Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems","volume":"44","author":"Piersimoni","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"3","key":"10.1016\/j.tube.2023.102412_bib50","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5152\/eurasianjmed.2017.17040","article-title":"Evaluation of the BACTEC MGIT 960 SL DST kit and the GenoType MTBDRsl test for detecting extensively drug-resistant tuberculosis cases","volume":"49","author":"Tekin","year":"2017","journal-title":"Eurasian J Med"},{"issue":"6","key":"10.1016\/j.tube.2023.102412_bib51","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1128\/JCM.02088-05","article-title":"Use of the GenoType Mycobacterium CM and AS assays to analyze 76 nontuberculous mycobacterial isolates from Greece","volume":"44","author":"Gitti","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2023.102412_bib52","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.meegid.2016.09.004","article-title":"Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis","volume":"45","author":"Unissa","year":"2016","journal-title":"Infect Genet Evol"},{"issue":"4","key":"10.1016\/j.tube.2023.102412_bib53","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijmyco.2014.08.003","article-title":"Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug","volume":"3","author":"Jena","year":"2014","journal-title":"Int J Mycobacteriol"},{"key":"10.1016\/j.tube.2023.102412_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111882","article-title":"Development of (4-methoxyphenyl)-1H-tetrazol-5-amine regioisomers as a new class of selective antitubercular agents","volume":"186","author":"Szulczyk","year":"2020","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.tube.2023.102412_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MGM2-0014-2013","article-title":"Resistance to isoniazid and ethionamide in Mycobacterium tuberculosis: genes, mutations, and causalities","volume":"2","author":"Vilcheze","year":"2014","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.tube.2023.102412_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119628","article-title":"Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review","volume":"10","author":"Seifert","year":"2015","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.tube.2023.102412_bib57","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.15.0864","article-title":"Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis","volume":"20","author":"Bollela","year":"2016","journal-title":"Int J Tubercul Lung Dis"},{"key":"10.1016\/j.tube.2023.102412_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1171861","article-title":"In vitro modeling of isoniazid resistance mechanisms in Mycobacterium tuberculosis H37Rv","volume":"14","author":"Dokrungkoon","year":"2023","journal-title":"Front Microbiol"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979223001105?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979223001105?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:47:40Z","timestamp":1761468460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979223001105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":58,"alternative-id":["S1472979223001105"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2023.102412","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antimycobacterial activity and interaction profiles of diarylthiourea-copper (II) complexes with antitubercular drugs against Mycobacterium tuberculosis isolates","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2023.102412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102412"}}